SENSEX NIFTY

Chemo Pharma La

Oct 07, 2016 at 13:06 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on October 24, 2016, to consider and approve the Un-Audited Financial Results for the quarter ended September 30, 2016.
Aug 31, 2016 at 14:40 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has submitted to BSE a copy of proceedings of 74th Annual General Meeting (AGM) of the Company held on August 30, 2016.
Jul 08, 2016 at 14:26 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on July 22, 2016, to consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2016
May 18, 2016 at 14:02 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2016.
Jan 22, 2016 at 14:46 | Source: Moneycontrol.com
Chemo-Pharma Laboratories has reported a sales total income from operations of Rs 0.03 crore and a net profit of Rs 0.01 crore for the quarter ended Dec '15
Jan 06, 2016 at 20:48 | Source: Moneycontrol.com
Chemo Pharma Laboratories' board meeting will be held on January 21, 2016, to transact the business and approve the Un-Audited Financial Results for the quarter ended December 31, 2015. To place and consider Uniform Listing Agreement with SEBI as per the reference to the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Dec 14, 2015 at 09:45 | Source: Moneycontrol.com
Natco and Alvogen have partnered on the first abbreviated new drug application (ANDA) containing a paragraph IV certification filed with the US Food and Drug Administration (FDA) for generic versions of Tamiflu oral capsules (oseltamivir phosphate), 30 mg, 45 mg and 75 mg.
Dec 14, 2015 at 09:29 | Source: Moneycontrol.com
Natco Pharma and Alvogen announced today that they have settled the patent infringement suit filed by Gilead Sciences, Inc., Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd. and Genentech, Inc. against Alvogen and Natco in New Jersey District Court.
Oct 28, 2015 at 10:30 | Source: Moneycontrol.com
Chemo-Pharma Laboratories has reported a sales total income from operations of Rs 0.13 crore and a net profit of Rs 0.09 crore for the quarter ended Sep '15
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.